Legal Opinion
In Re Avandia Marketing Sales Practices & Products Liability Litigation
Court of Appeals for the Third Circuit
Decided February 12, 2016No. 15-2145UnpublishedCited by 1 opinion
1Opinion of the Court
OPINION *
COWEN, Circuit Judge.
Plaintiff Staci Laurino appeals from the order of the United States District Court for the Eastern District of Pennsylvania granting the motion to dismiss filed by Defendant GlaxoSmithKline LLC (“GSK”). We will affirm.
I
Laurino is a former user of Avandia, a prescription diabetes drug manufactured by GSK. The drug works by lowering blood sugar levels. On behalf of a putative class of similarly situated individuals, she alleged that GSK violated the Missouri Merchandising Practices Act (“MMPA”). According to her amended complaint, GSK, even though it had notice of…
2Cases cited9 opinions
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Thomas Foglia v. Renal Ventures ManagementCourt of Appeals for the Third Circuit · 2014
- General Refractories Company Grefco, Inc. v. Fireman's Fund Insurance Company Gilberg & Kiernan Andrew Butz General Refractories CompanyCourt of Appeals for the Third Circuit · 2003
- State Farm Mutual Automobile Insurance Company v. Leonard Coviello Mary Coviello, H/w Ann CovielloCourt of Appeals for the Third Circuit · 2000
- Plubell v. Merck & Co., Inc.Missouri Court of Appeals · 2009
4 more not listed; retrieve them via the Exa API.
3Cited by1 opinion
- Aaron Leigh-Pink v. Rio Properties, LLCCourt of Appeals for the Ninth Circuit · 2021